These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 22840300)

  • 1. Anticoagulation management pre- and post atrial fibrillation ablation: a survey of canadian centres.
    Mardigyan V; Verma A; Birnie D; Guerra P; Redfearn D; Becker G; Champagne J; Sapp J; Gula L; Parkash R; Macle L; Crystal E; O'Hara G; Khaykin Y; Sturmer M; Veenhuyzen GD; Greiss I; Sarrazin JF; Mangat I; Novak P; Skanes A; Roux JF; Chauhan V; Hadjis T; Morillo CA; Essebag V
    Can J Cardiol; 2013 Feb; 29(2):219-23. PubMed ID: 22840300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
    Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
    Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score ≤3: a long-term outcome study.
    Saad EB; d'Avila A; Costa IP; Aryana A; Slater C; Costa RE; Inácio LA; Maldonado P; Neto DM; Camiletti A; Camanho LE; Polanczyk CA
    Circ Arrhythm Electrophysiol; 2011 Oct; 4(5):615-21. PubMed ID: 21841192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periprocedural anticoagulation for atrial fibrillation ablation.
    Mortada ME; Chandrasekaran K; Nangia V; Dhala A; Blanck Z; Cooley R; Bhatia A; Gilbert C; Akhtar M; Sra J
    J Cardiovasc Electrophysiol; 2008 Apr; 19(4):362-6. PubMed ID: 18284509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary vein antrum isolation for atrial fibrillation on therapeutic coumadin: special considerations.
    Gopinath D; Lewis WR; Di Biase L; Natale A
    J Cardiovasc Electrophysiol; 2011 Feb; 22(2):236-9. PubMed ID: 21044211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
    Lakkireddy D; Reddy YM; Di Biase L; Vallakati A; Mansour MC; Santangeli P; Gangireddy S; Swarup V; Chalhoub F; Atkins D; Bommana S; Verma A; Sanchez JE; Burkhardt JD; Barrett CD; Baheiry S; Ruskin J; Reddy V; Natale A
    J Am Coll Cardiol; 2014 Mar; 63(10):982-8. PubMed ID: 24412445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation.
    Eitel C; Koch J; Sommer P; John S; Kircher S; Bollmann A; Arya A; Piorkowski C; Hindricks G
    Europace; 2013 Nov; 15(11):1587-93. PubMed ID: 23703362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CHADS score role in managing anticoagulation after surgical ablation for atrial fibrillation.
    Ad N; Henry L; Schlauch K; Holmes SD; Hunt S
    Ann Thorac Surg; 2010 Oct; 90(4):1257-62. PubMed ID: 20868824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of late thromboembolic events after catheter ablation of atrial fibrillation.
    Yagishita A; Takahashi Y; Takahashi A; Fujii A; Kusa S; Fujino T; Nozato T; Kuwahara T; Hirao K; Isobe M
    Circ J; 2011; 75(10):2343-9. PubMed ID: 21778595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral anticoagulant use around the time of atrial fibrillation ablation: a review of the current evidence of individual oral anticoagulant use for periprocedural atrial fibrillation ablation thromboembolic prophylaxis.
    Garton AB; Dudzinski J; Kowey PR
    J Cardiovasc Electrophysiol; 2014 Dec; 25(12):1411-8. PubMed ID: 25216104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and predictors of periprocedural cerebrovascular accident in patients undergoing catheter ablation of atrial fibrillation.
    Scherr D; Sharma K; Dalal D; Spragg D; Chilukuri K; Cheng A; Dong J; Henrikson CA; Nazarian S; Berger RD; Calkins H; Marine JE
    J Cardiovasc Electrophysiol; 2009 Dec; 20(12):1357-63. PubMed ID: 19572951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation.
    Chao TF; Lin YJ; Tsao HM; Tsai CF; Lin WS; Chang SL; Lo LW; Hu YF; Tuan TC; Suenari K; Li CH; Hartono B; Chang HY; Ambrose K; Wu TJ; Chen SA
    J Am Coll Cardiol; 2011 Nov; 58(23):2380-5. PubMed ID: 22115643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of switching anticoagulation to aspirin three months after successful radiofrequency catheter ablation of atrial fibrillation.
    Uhm JS; Won H; Joung B; Nam GB; Choi KJ; Lee MH; Kim YH; Pak HN
    Yonsei Med J; 2014 Sep; 55(5):1238-45. PubMed ID: 25048480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of anticoagulation during the periprocedure period of atrial fibrillation ablation.
    Verma A; Tsang B
    Curr Opin Cardiol; 2012 Jan; 27(1):55-61. PubMed ID: 22146378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Periprocedural management of anticoagulation in patients undergoing atrial fibrillation ablation].
    Park CI; Pruvot E; Jadidi A; Lehrmann H; Weber R; Arentz T; Zimmermann M
    Rev Med Suisse; 2015 Mar; 11(464):557-60, 562. PubMed ID: 25924251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Experience of Novel Oral Anticoagulants in Catheter Ablation for Atrial Fibrillation: Efficacy and Safety Comparison to Warfarin.
    Shin DG; Kim TH; Uhm JS; Kim JY; Joung B; Lee MH; Pak HN
    Yonsei Med J; 2016 Mar; 57(2):342-9. PubMed ID: 26847285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter ablation of atrial fibrillation in patients at low thrombo-embolic risk: efficacy and safety of a simplified periprocedural anticoagulation strategy.
    Duytschaever M; Berte B; Acena M; De Meyer G; Bun SS; Van Heuverswyn F; Vandekerckhove Y; Tavernier R
    J Cardiovasc Electrophysiol; 2013 Aug; 24(8):855-60. PubMed ID: 23600918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of periprocedural anticoagulation strategies on complication rate and hospital stay in patients undergoing catheter ablation for persistent atrial fibrillation.
    Gunawardene M; Willems S; Schäffer B; Moser J; Akbulak RÖ; Jularic M; Eickholt C; Nührich J; Meyer C; Kuklik P; Sehner S; Czerner V; Hoffmann BA
    Clin Res Cardiol; 2017 Jan; 106(1):38-48. PubMed ID: 27435077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of dabigatran immediately after atrial fibrillation ablation.
    Winkle RA; Mead RH; Engel G; Kong MH; Patrawala RA
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):264-8. PubMed ID: 21955008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio.
    Di Biase L; Burkhardt JD; Mohanty P; Sanchez J; Horton R; Gallinghouse GJ; Lakkireddy D; Verma A; Khaykin Y; Hongo R; Hao S; Beheiry S; Pelargonio G; Dello Russo A; Casella M; Santarelli P; Santangeli P; Wang P; Al-Ahmad A; Patel D; Themistoclakis S; Bonso A; Rossillo A; Corrado A; Raviele A; Cummings JE; Schweikert RA; Lewis WR; Natale A
    Circulation; 2010 Jun; 121(23):2550-6. PubMed ID: 20516376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.